Eleftha 440mg Injection - Trastuzumab

Eleftha 440mg Injection is a prescription medication containing Trastuzumab (440mg), used to treat certain types of cancer. It's indicated for the treatment of HER2-positive breast cancer in adult patients with advanced or metastatic disease who have received prior chemotherapy.

This injectable medication works by targeting the human epidermal growth factor receptor 2 (HER2), a protein that contributes to the growth and spread of some cancers. Eleftha binds to this protein, effectively inhibiting tumor cell growth and proliferation.

Key features:

* Proven efficacy: Demonstrated effectiveness in treating HER2-positive breast cancer
* Convenient administration: Delivered via single injection for easy and safe dosage control
* Prescribed by healthcare professionals: Requires a doctor's authorization for proper use and dosage

Important: This medication should only be administered under the guidance of a qualified healthcare professional. Before starting treatment, discuss potential side effects and drug interactions with your physician.

***
Please Note: This information is for general knowledge purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before using any medications.